{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:12:33Z","timestamp":1772755953080,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.semcancer.2003.09.011","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T13:04:02Z","timestamp":1069333442000},"page":"473-480","source":"Crossref","is-referenced-by-count":45,"title":["Active-specific immunization against melanoma: Is the problem at the receiving end?"],"prefix":"10.1016","volume":"13","author":[{"given":"Vladia","family":"Monsurr\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ena","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica C","family":"Panelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Nagorsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zavaglia","family":"Katia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kina","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Ngalame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos","family":"Even","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco M","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2003.09.011_BIB1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00008390-199510000-00001","article-title":"Somatic gene therapy of human melanoma: preclinical studies and early clinical trials","volume":"5","author":"Parmiani","year":"1995","journal-title":"Melanoma. Res."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/94.11.805","article-title":"Cancer immunotherapy with peptide-based vaccines: What have we achieved? Where are we going?","volume":"94","author":"Parmiani","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-5699(97)84664-6","article-title":"Cancer vaccines based on the identification of genes encoding cancer regression antigens","volume":"18","author":"Rosenberg","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.187.8.1163","article-title":"New Paths in Human Cancer Serology","volume":"187","author":"Old","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ni1102-999","article-title":"Natural selection of tumor variants in the generation of \u201ctumor escape\u201d phenotypes","volume":"3","author":"Khong","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1471-4906(03)00116-9","article-title":"Tumors as elusive targets of T cell-directed immunotherapy","volume":"24","author":"Marincola","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB9","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.4049\/jimmunol.163.11.6292","article-title":"Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression","volume":"163","author":"Lee","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB10","first-page":"796s","article-title":"Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide","volume":"7","author":"Pittet","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","article-title":"Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma","volume":"190","author":"Thurner","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00002371-200003000-00012","article-title":"Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma","volume":"23","author":"Scheibenbogen","year":"2000","journal-title":"J. Immunother."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1399-0039.1996.tb02556.x","article-title":"Three new DPB1 alleles identified in a Bantu-speaking population from central Cameroon","volume":"47","author":"Zimmerman","year":"1996","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0092-8674(02)01139-X","article-title":"Molecular and functional profiling of memory CD8 T cell differentiation","volume":"111","author":"Kaech","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-3083.2001.00973.x","article-title":"Danger model of immunity","volume":"54","author":"Matzinger","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB18","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1073\/pnas.86.17.6719","article-title":"Selective changes in expression of HLA class I polymorphic determinants in human solid tumors","volume":"86","author":"Natali","year":"1989","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60911-6","article-title":"Escape of human solid tumors from T cell recognition: molecular mechanisms and functional significance","volume":"74","author":"Marincola","year":"2000","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0","article-title":"Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma","volume":"71","author":"Jager","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0167-5699(97)01052-9","article-title":"TAP off\u2014Tumors on","volume":"18","author":"Seliger","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0167-5699(00)01692-3","article-title":"Antigen-processing machinery breakdown and tumor growth","volume":"21","author":"Seliger","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB23","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4049\/jimmunol.167.3.1809","article-title":"Short term kinetics of tumor antigen expression in response to vaccination","volume":"167","author":"Ohnmacht","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB24","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.4049\/jimmunol.163.12.6867","article-title":"Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens","volume":"163","author":"Kammula","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4049\/jimmunol.164.1.495","article-title":"Expansion of tumor\/T cell pairs from fine needle aspirates (FNA) of melanoma metastases","volume":"164","author":"Panelli","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB26","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4049\/jimmunol.162.3.1827","article-title":"A re-evaluation of the frequency of CD8(+) T cells specific for EBV in healthy virus carriers","volume":"162","author":"Tan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB28","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/00007890-200110270-00012","article-title":"Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells","volume":"72","author":"Haque","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/oxfordjournals.jncimonographs.a024180","article-title":"Immunotherapy of Epstein-Barr virus-associated cancer","volume":"23","author":"Rooney","year":"1998","journal-title":"J. Natl. Cancer Institut. Monogr."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/blood.V99.1.88","article-title":"Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load","volume":"99","author":"Yamano","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4049\/jimmunol.168.1.338","article-title":"Intensity of the vaccine-elicited immune response determines tumor clearence","volume":"168","author":"Perez-Diez","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB32","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.4049\/jimmunol.166.9.5817","article-title":"Kinetics of TCR use in response to repeated epitope-specific immunization","volume":"166","author":"Monsurr\u00f2","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/9525","article-title":"Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients","volume":"5","author":"Lee","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB34","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.4049\/jimmunol.167.11.6165","article-title":"The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells","volume":"167","author":"Speiser","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB35","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.4049\/jimmunol.165.4.2287","article-title":"Status of activation of circulating vaccine-elicited CD8+ T cells","volume":"165","author":"Nielsen","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB36","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.4049\/jimmunol.166.12.7634","article-title":"Ex vivo IFN-\u03b3 secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases","volume":"166","author":"Pittet","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.192.1.63","article-title":"HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function","volume":"192","author":"Appay","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotype and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/35065118","article-title":"Skewed maturation of memory HIV-specific CD8 T lymphoctes","volume":"410","author":"Champagne","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB41","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.4049\/jimmunol.168.11.5933","article-title":"Functional heterogeneity of vaccine-induced CD8+ T cells","volume":"168","author":"Monsurro\u2019","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni845","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforing expression and is maintained in nonprogressors","volume":"3","author":"Migueles","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S1471-4906(02)02326-8","article-title":"Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue","volume":"23","author":"van Baarle","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB44","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/1521-4141(200203)32:3<731::AID-IMMU731>3.0.CO;2-H","article-title":"In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells","volume":"32","author":"Speiser","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2003.09.011_BIB45","first-page":"1","article-title":"Interleukin-2","volume":"4","author":"Marincola","year":"1994","journal-title":"Biol. Ther. Cancer Updates"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00000658-198910000-00008","article-title":"Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients","volume":"210","author":"Rosenberg","year":"1989","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0167-5699(97)80020-5","article-title":"Tumor antigens recognized by T cells","volume":"18","author":"Boon","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB48","first-page":"37","article-title":"Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1\/Melan A [see comments]","volume":"3","author":"Cormier","year":"1997","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nm0398-321","article-title":"Immunologic and therapeutic evaluation of a synthetic tumor associated peptide vaccine for the treatment of patients with metastatic melanoma","volume":"4","author":"Rosenberg","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB50","first-page":"189","article-title":"The role of antigen in maintaining T cell memory","volume":"82","author":"Zinkernagel","year":"1994","journal-title":"Dev. Biol. Stand"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB51","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri779","article-title":"The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?","volume":"2","author":"McMichael","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri1052","article-title":"Cytokine control of memory T-cell development and survival","volume":"3","author":"Schluns","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB53","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.bjc.6600679","article-title":"Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2","volume":"88","author":"DePaola","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB54","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H","article-title":"Localization of 111 indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response","volume":"73","author":"Pockaj","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB55","doi-asserted-by":"crossref","unstructured":"Panelli MC, Wang E, Phan G, Puhlman M, Miller L, Ohnmacht GA, Klein H, Marincola FM. Genetic profiling of peripharal mononuclear cells and melanoma metastases in response to systemic interleukin-2 administration. Genome Biol 2002;3 [RESEARCH0035].","DOI":"10.1186\/gb-2002-3-7-research0035"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB56","doi-asserted-by":"crossref","unstructured":"Panelli MC, Martin B, Nagorsen D, Wang E, Smith K, Monsurro\u2019 V, Marincola FM. A genomic and proteomic-based hypothesis on the eclectic effects of systemic interleukin-2 administration in the context of melanoma-specific immunization. J Invest Dermatol, in press.","DOI":"10.1159\/000079986"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB57","unstructured":"Sarwal, M. Gene expression profiling of allograft rejection using cDNA microarrays. In: Proceedings of the 27th Annual Meeting of American Society for Histocompatibility and Immunogenetics, 2001 January 1."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0041-1345(01)01917-0","article-title":"Genomic analysis of renal allograft dysfunction using cDNA microarrays","volume":"33","author":"Sarwal","year":"2001","journal-title":"Transplant Proc."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB59","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0167-5699(00)01724-2","article-title":"A natural history of melanoma: serial gene expression analysis","volume":"21","author":"Wang","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB60","first-page":"3581","article-title":"Prospective molecular profiling of subcutaneous melanoma metastases suggests classifiers of immune responsiveness","volume":"62","author":"Wang","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB61","unstructured":"Wang E, Panelli MC, Marincola FM. Genomic analysis of cancer. Princ Pract Oncol, in press."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.gene.6363726","article-title":"IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma","volume":"2","author":"Howell","year":"2001","journal-title":"Genes Immun."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.gene.6363851","article-title":"Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma","volume":"3","author":"Howell","year":"2002","journal-title":"Genes Immun."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB64","doi-asserted-by":"crossref","unstructured":"Wang E, Adams S, Zhao Y, Panelli MC, Simon R, Klein H, Marincola FM. A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides. J Transl Med, 1: 4.","DOI":"10.1186\/1479-5876-1-4"},{"key":"10.1016\/j.semcancer.2003.09.011_BIB65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-1-1","article-title":"Translational medicine: a two way road","volume":"1","author":"Marincola","year":"2003","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2003.09.011_BIB66","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/74546","article-title":"High fidelity mRNA amplification for gene profiling using cDNA microarrays","volume":"17","author":"Wang","year":"2000","journal-title":"Nat. Biotech."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X03000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X03000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T12:42:01Z","timestamp":1704976921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X03000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1044579X03000786"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2003.09.011","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}